Does the fat anterior to the psoas (major muscle in the lower back) below the lower pole of the left kidney contain lymph nodes, participate in the lymphatic chain for the kidneys, or serve as a location for metastatic lymph nodes from renal (kidney) cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The fat anterior to the psoas below the lower pole of the left kidney does contain lymph nodes and is an important part of the lymphatic drainage pathway for the kidneys. This area is a common site for metastatic lymph nodes from kidney cancer, as renal cell carcinoma typically spreads via lymphatic routes, and the lymphatic drainage of the kidneys follows a predictable pattern through the hilar, paracaval, para-aortic, and interaortocaval lymph nodes 1. The left kidney specifically drains to lymph nodes along the left renal vein, the para-aortic chain, and nodes anterior to the psoas muscle. Key points to consider include:

  • The importance of evaluating this area during surgical management of kidney cancer, particularly radical nephrectomy with lymph node dissection, as it is often included in the lymphadenectomy field 1.
  • The role of imaging studies such as CT scans with contrast in assessing this region when evaluating for potential metastatic disease from kidney cancer, as enlarged nodes in this location may represent the first sign of lymphatic spread.
  • The recommendation for lymph node dissection for patients with palpable or CT-detected enlarged lymph nodes, and for those with normal-appearing nodes to obtain adequate staging information 1. Considering the potential for lymph node involvement and metastasis, it is crucial to carefully assess and manage this area in the context of kidney cancer treatment, prioritizing morbidity, mortality, and quality of life outcomes.

From the Research

Lymph Node Involvement in Renal Cell Carcinoma

  • The presence of lymph node metastases in renal cell carcinoma (RCC) is a significant prognostic factor, doubling the patient's risk of distant metastasis and reducing their 5-year survival rate 2.
  • Lymph node involvement in RCC can be evaluated using various modalities, including color Doppler sonography, magnetic resonance imaging (MRI), lymphotrophic nanoparticle enhanced MRI, multidetector-row computed tomography (MDCT), F-fluoro-2-deoxyglucose positron emission tomography (FDG-PET), and PET/CT 2.
  • MRI has been shown to have the highest sensitivity (92-95.7%) for detecting lymph node involvement in RCC, while FDG-PET has the highest specificity (100%) for confirming lymph node involvement and extent of involvement 2.

Fat Anterior to the Psoas Major and Lymph Node Involvement

  • There is no direct evidence in the provided studies to suggest that the fat anterior to the psoas major below the lower pole of the left kidney contains lymph nodes or participates in the lymphatic chain for the kidneys.
  • However, studies have shown that lymph node metastases in RCC can occur in various locations, including the renal hilus, para-aortic, and paracaval regions 3, 4.
  • The presence of enlarged lymph nodes in the vicinity of the kidney does not always indicate metastatic disease, as inflammatory changes and/or follicular hyperplasia can also cause lymph node enlargement 4.

Metastatic Lymph Nodes from Renal Cancer

  • Metastatic lymph nodes from renal cancer can occur in various locations, including the retroperitoneal lymph nodes 5, 3.
  • The study by 3 found that subdiaphragmatic lymph node metastases were associated with poor prognosis in metastatic RCC patients treated with targeted therapies.
  • The study by 4 found that enlarged lymph nodes in patients with RCC were often not due to metastases, but rather inflammatory changes and/or follicular hyperplasia.

Related Questions

Is the fat anterior to the psoas muscle below the lower pole of the left kidney part of the lymphatic chain for left kidney (Lkidney) cancer lymph node metastasis?
Is the fat anterior to the psoas muscle (Psoas (muscle)) below the lower pole of the left kidney part of the lymphatic chain for renal (kidney) cancer?
Is fat anterior or lateral to the psoas (muscle) muscle caudal to the lower pole of the left kidney an uncommon location for lymph node metastasis in kidney cancer?
Is the fat anterior to the psoas muscle below the lower pole of the left kidney part of the lymphatic chain for kidney cancer (renal cell carcinoma) lymph node metastasis?
Is the fat located anterior to the psoas (muscle) and below the lower pole of the left kidney part of the lymphatic chain for renal (kidney) cancer?
What is the most likely diagnosis for a 50-year-old patient with a magnetic resonance imaging (MRI) lesion that is isointense on T1 sequences, hyperintense on T2 sequences, with homogeneous enhancement on gadolinium (Gd) contrast administration, and dural extension?
What is the use of Leflunomide?
Can the herpes zoster (shingles), tetanus, and pneumococcal (pneumonia) vaccines be administered on the same day?
Is removal of a 1 centimeter (cm) mature cystic teratoma (dermoid cyst) of the ovary recommended to improve fertility in a female patient with infertility?
What is the most effective ointment for shrinking external thrombosed hemorrhoids (External Hemorrhoidal Disease)?
Does the fat anterior to the psoas muscle, located below the lower pole of the left kidney, lack lymph nodes and is it not a site for metastatic lymph nodes from renal (kidney) cancer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.